Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 887389104 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Vanguard Group Inc 13G/A Amendment 10 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
4.3% |
2/13/2026
Event 12/31/2025
|
|
| American Century Investment Management, Inc. | 4.3% | ||
| American Century Companies, Inc. | 4.3% | ||
| Stowers Institute for Medical Research | 4.3% | ||
|
FMR LLC
13G/A
Amendment 2
|
4.0% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 4.0% | ||
| Abigail P. Johnson | 4.0% | ||
|
FMR LLC
13G/A
Amendment 1
|
5.1% |
8/6/2025
Event 6/30/2025
|
|
| FMR LLC | 5.1% | ||
| Abigail P. Johnson | 5.1% | ||
|
American Century Investment Management, Inc.
13G
|
5.0% |
2/14/2025
Event 12/31/2024
|
|
| American Century Investment Management, Inc. | 5.0% | ||
| American Century Companies, Inc. | 5.0% | ||
| Stowers Institute for Medical Research | 5.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 81 | 1.71 M | $200 M |
| 2026 Q2 | 629 | 76.4 M | $9.56 B |
| 2026 Q1 | 546 | 62.2 M | $6.26 B |
| 2025 Q4 | 484 | 65.8 M | $5.54 B |
| 2025 Q3 | 443 | 65.1 M | $4.88 B |
| 2025 Q2 | 457 | 63.1 M | $4.58 B |
| 2025 Q1 | 438 | 62.3 M | $4.47 B |
| 2024 Q4 | 458 | 60.3 M | $4.30 B |
| 2024 Q3 | 490 | 61.2 M | $5.15 B |
| 2024 Q2 | 472 | 62.9 M | $5.03 B |
| 2024 Q1 | 464 | 63.6 M | $5.56 B |
| 2023 Q4 | 470 | 63.3 M | $5.07 B |
| 2023 Q3 | 444 | 59.6 M | $4.37 B |
| 2023 Q2 | 436 | 61.3 M | $5.57 B |
| 2023 Q1 | 447 | 62.9 M | $5.08 B |
| 2022 Q4 | 417 | 62.2 M | $4.41 B |
| 2022 Q3 | 362 | 60.2 M | $3.56 B |
| 2022 Q2 | 356 | 59.6 M | $3.16 B |
| 2022 Q1 | 370 | 61.0 M | $3.70 B |
| 2021 Q4 | 356 | 60.7 M | $4.21 B |
| 2021 Q3 | 366 | 60.7 M | $3.97 B |
| 2021 Q2 | 398 | 61.8 M | $4.98 B |
| 2021 Q1 | 399 | 61.0 M | $4.95 B |
| 2020 Q4 | 419 | 64.1 M | $4.96 B |
| 2020 Q3 | 368 | 61.2 M | $3.32 B |
| 2020 Q2 | 332 | 61.7 M | $3.33 B |
| 2020 Q1 | 327 | 60.1 M | $2.83 B |
| 2019 Q4 | 373 | 61.5 M | $3.46 B |
| 2019 Q3 | 359 | 58.4 M | $2.54 B |
| 2019 Q2 | 391 | 61.0 M | $3.17 B |
| 2019 Q1 | 358 | 60.5 M | $2.64 B |
| 2018 Q4 | 334 | 60.1 M | $2.25 B |
| 2018 Q3 | 380 | 62.8 M | $3.13 B |
| 2018 Q2 | 363 | 61.2 M | $2.67 B |
| 2018 Q1 | 352 | 61.1 M | $2.77 B |
| 2017 Q4 | 346 | 61.8 M | $3.04 B |
| 2017 Q3 | 320 | 62.2 M | $3.02 B |
| 2017 Q2 | 343 | 62.9 M | $2.91 B |
| 2017 Q1 | 337 | 61.4 M | $2.78 B |
| 2016 Q4 | 315 | 62.9 M | $2.50 B |
| 2016 Q3 | 299 | 66.7 M | $2.34 B |
| 2016 Q2 | 300 | 60.0 M | $1.84 B |
| 2016 Q1 | 278 | 61.4 M | $2.05 B |
| 2015 Q4 | 284 | 64.3 M | $1.84 B |
| 2015 Q3 | 279 | 69.1 M | $1.89 B |
| 2015 Q2 | 305 | 65.0 M | $2.38 B |
| 2015 Q1 | 313 | 67.8 M | $2.88 B |
| 2014 Q4 | 344 | 72.1 M | $3.10 B |
| 2014 Q3 | 336 | 68.2 M | $2.92 B |
| 2014 Q2 | 359 | 70.3 M | $4.78 B |
| 2014 Q1 | 343 | 69.5 M | $4.11 B |